Your session is about to expire
← Back to Search
MyoVoice for Speech Disorder
Study Summary
This trial will study whether MyoVoice can help people with cancer who can't speak communicate better than they could without it.
- Speech Disorder
- Speech and Language Therapy
- Alaryngeal Speech
- Assistive Communication Devices
- Speech Perception
- Speech Clarity
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What objectives is this experiment attempting to accomplish?
"The trial sponsor, Altec Inc., has outlined the primary and secondary outcome measures for this experiment. The main endpoint is System Usability Scale which will be assessed over a 1 hour period; subsequent metrics of assessment include Prosodic sEMG-Acoustic Correlation, Acceptability, and Emotional Content - wherein naive listeners rate samples on seven fundamental emotions."
How many individuals are being recruited for this clinical research?
"Accurate. The clinicaltrials.gov website states that this trial is currently recruiting participants, having been initially posted on February 12th 2021 and most recently updated on March 18 2022. Participants are needed from one location only, with a total of 28 enrolments sought after."
Are there any openings in the clinical trial for enrollees?
"As per clinicaltrials.gov, the trial is still accepting participants; this study was posted on February 12th 2021 and its details were recently updated on March 18th 2022."
Share this study with friends
Copy Link
Messenger